HEXAHYDROCANNABINOLSsynthetic cannabinoid derivatives

 

Hexahydrocannabinols, novel synthetic cannabinoid derivatives, suppress the tumor growth by inhibiting the VEGF secretion and angiogenesis                                                                         (abst – 2009)  http://www.fasebj.org/cgi/content/meeting_abstract/23/1_MeetingAbstracts/761.3?maxtoshow=&hits=10&   RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspe  c=relevance&resourcetype=HWCIT

 

Involvement of NSAID-activated gene-1 in a novel synthetic hexahydrocannabinol analogue-induced growth inhibition and apoptosis of colon cancer cells                                                                (abst – 2010)  http://www.fasebj.org/cgi/content/meeting_abstract/24/1_MeetingAbstracts/965.8?maxtoshow=&hits=80&   RESULTFORMAT=&fulltext=Hexahydrocannabinol&searchid=1&FIRSTINDEX=0&resourcetype=HW  CIT

 

Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells

(abst – 2010)

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T4P-4YM7FF0-  2&_user=10&_coverDate=07%2F01%2F2010&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor

=&view=c&_searchStrId=1313682160&_rerunOrigin=scholar.google&_acct=C000050221&_version=1&

_urlVersion=0&_userid=10&md5=6f222e32968fcf27444674d5217dcecb

 

Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.                                                                                    (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/20950604

 

Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia- inducible factor-1α activation.          (full – 2012)  https://www.jstage.jst.go.jp/article/bpb/35/6/35_b12-00020/_pdf

 

Share a link for